New Funding Opportunity for NIA IMPACT Collaboratory Pilot Grants
The NIA IMPACT Collaboratory has published a Request for Applications (RFA) for Pilot Grants with Letters of Intent due September 17, 2021.
The National Institute on Aging (NIA) Imbedded Pragmatic Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias Clinical Trials (IMPACT) Collaboratory funds several one-year awards of pilot pragmatic clinical trials (ePCTs) that test non-pharmacological interventions embedded in health care system(s) for people living with Alzheimer’s Disease (AD) and AD-related dementias (ADRD) and their care partners. Under this mechanism, interventions must be linked to the needs of a health care system.
All applications will be considered with priority given to applications for interventions in this population that aim to:
- Reduce inequities in health care;
- Reduce potentially inappropriate medications through de-prescribing; and
- Improve care in emergency department.
The goal of the pilot projects is to generate the preliminary data necessary to design and conduct a future full-scale Stage IV effectiveness ePCT (based on the NIH Stage Model). The IMPACT Collaboratory will give preference to applications that address dementia care for populations traditionally marginalized or underrepresented in clinical trials and those that promote health equity. It is anticipated that Pilot Projects will be funded for up to $175,000 in direct costs for a maximum of 12-months.
If you have questions related to this funding opportunity, please contact IMPACTcollaboratory@hsl.harvard.edu.
To register for an August 23 informational webinar about the IMPACT Pilot Grant Program Cycle 3B, click here.
To learn more, click here.
To go to the RFA, click here.
To learn more about IMPACT Collaboratory pilot grant opportunities, click here.
